Express Healthcare

facebook
twitter
Email

Express Healthcare

Browsing tag

CKD patients

AstraZeneca’s Dapagliflozin gets marketing authorisation for chronic kidney disease in India

Home
Advertise With Us
About Us
Contact Us
Submit Press Release
Privacy Policy

View Desktop Version